Pathogenic potential of Escherichia coli from polymicrobial urinary tract infections

References

1. Anderson G. G., Palermo J. J., Schilling J. D., Roth R., Heuser J., Hultgren S. J. 2003; Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105–107 [View Article][PubMed]
   [Google Scholar]
2. Brzuszkiewicz E., Brüggemann H., Liesegang H., Emmerth M., Olschläger T., Nagy G., Albermann K., Wagner C., Buchrieser C. et al. 2006; How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci U S A 103:12879–12884 [View Article][PubMed]
   [Google Scholar]
3. Croxall G., Weston V., Joseph S., Manning G., Cheetham P., McNally A. 2011; Increased human pathogenic potential of Escherichia coli from polymicrobial urinary tract infections in comparison to isolates from monomicrobial culture samples. J Med Microbiol 60:102–109 [View Article][PubMed]
   [Google Scholar]
4. Domann E., Hong G., Imirzalioglu C., Turschner S., Kühle J., Watzel C., Hain T., Hossain H., Chakraborty T. 2003; Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients. J Clin Microbiol 41:5500–5510 [View Article][PubMed]
   [Google Scholar]
5. Foxman B., Brown P. 2003; Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 17:227–241 [View Article][PubMed]
   [Google Scholar]
6. Houdouin V., Bonacorsi S., Mahjoub-Messai F., Mariani-Kurkdjian P., Bidet P., Sebag G., Loirat C., Bourrillon A., Bingen E. 2007; Phylogenetic groups and virulence factors of Escherichia coli strains causing pyelonephritis in children with and without urinary tract abnormalities. Clin Microbiol Infect 13:740–742 [View Article][PubMed]
   [Google Scholar]
7. Johnson J. R. 1991; Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4:80–128[PubMed]
   [Google Scholar]
8. Johnson J. R. 2005; Virulence factors in Escherichia coli. J Clin Microbiol 43:6221–6221 [View Article][PubMed]
   [Google Scholar]
9. Mulvey M. A., Schilling J. D., Hultgren S. J. 2001; Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69:4572–4579 [View Article][PubMed]
   [Google Scholar]
10. Platell J. L., Cobbold R. N., Johnson J. R., Trott D. J. 2010; Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J Antimicrob Chemother 65:1936–1938 [View Article][PubMed]
    [Google Scholar]
11. Ronald A. 2003; The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 49:71–82 [View Article][PubMed]
    [Google Scholar]
12. Saverino D., Schito A. M., Mannini A., Penco S., Bassi A. M., Piatti G. 2011; Quinolone/fluoroquinolone susceptibility in Escherichia coli correlates with human polymicrobial bacteriuria and with in vitro interleukine-8 suppression. FEMS Immunol Med Microbiol 61:84–93 [View Article][PubMed]
    [Google Scholar]
13. Siegman-Igra Y., Kulka T., Schwartz D., Konforti N. 1994; Polymicrobial and monomicrobial bacteraemic urinary tract infection. J Hosp Infect 28:49–56 [View Article][PubMed]
    [Google Scholar]
14. Takahashi A., Muratani T., Yasuda M., Takahashi S., Monden K., Ishikawa K., Kiyota H., Arakawa S., Matsumoto T. et al. 2009; Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns. J Clin Microbiol 47:791–795 [View Article][PubMed]
    [Google Scholar]
15. Thomson C. J. 1993; Trimethoprim and brodimoprim resistance of gram-positive and gram-negative bacteria. J Chemother 5:458–464[PubMed]
    [Google Scholar]